ArticleInternational journal of colorectal disease2025
Modified sclerobanding versus rubber band ligation for grade II/III hemorrhoidal disease: a retrospective study.
Article in International journal of colorectal disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThis study aimed to evaluate the efficacy and safety of a modified sclerobanding (mSB) procedure, which combines rubber band ligation (RBL) with 3% polidocanol foam sclerotherapy (PFS), for treating grade II/III hemorrhoidal disease (HD).
methodsWe retrospectively included patients with grade II/III HD who underwent RBL from January to December 2021 and mSB from January 2022 to February 2023 at Ningbo Medical Center Lihuili Hospital. The primary outcomes assessed were treatment failure rates and the incidence of delayed massive bleeding (DMB), while the secondary outcomes included postoperative complications such as pain, swelling, anal edema, and variations in bleeding grade. Long-term follow-up evaluated the HD Symptom Score (HDSS), Short Health Scale for HD (SHS-HD), and Patient Satisfaction (PS).
resultsAmong the 307 patients, 162 received mSB and 125 underwent traditional RBL. The baseline characteristics were similar, except for the anticoagulant history and hospital stay length (P < 0.05). The mSB group had no cases of delayed major bleeding, compared to five cases in the RBL group. The recurrence (6.8% vs. 17.0%) and treatment failure (6.8% vs. 18.6%) rates were significantly lower in the mSB group (P < 0.05). Postoperative complications were comparable between the groups, but the mSB group showed greater improvement in bleeding by the seventh day (P < 0.05). One-year follow-up revealed no significant differences in the HDSS, SHS-HD, or PS.
conclusionsThe modified sclerobanding procedure reduces the number of ligation sessions, lowers the risk of delayed bleeding, and decreases treatment failure rates without increasing the risk of postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.